IL6 and inflammatory bowel disease: The aim of the present prospective observational study was to systematically analyse serum IL-6 and sIL-2R levels in a cohort of IBD patients and to evaluate the correlation between these laboratory markers of inflammation with clinical and endoscopic disease activity status in IBD patients.